3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
6
Venous Thromboembolism
2
Thrombosis
2
Thromboembolism
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Venous Thrombosis
1
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Sarcoma, Alveolar Soft Part
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Prostate Cancer Patients
1
Pneumonia
1
Pharmacokinetics of MDV3100
1
Pain
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasm Metastasis
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Interventions
Dalteparin
7
apixaban
5
edoxaban
4
Rivaroxaban
3
Enoxaparin
3
Tinzaparin
2
Heparin
2
Fondaparinux
2
Dabigatran
2
calcium heparin
1
bemiparin
1
Warfarin
1
Ultrasonography, Doppler, Duplex
1
Rosuvastatin Calcium
1
Nadroparin
1
Heparin, Low-Molecular-Weight
1
Data Collection
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Venous Thrombosis
×
Warfarin
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts